Dr. John Rothman, EVP of Science & Operations of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, moderated a panel discussion titled, “Live Cancer Vaccines.”
No Comments »
Filed under: Pharmacy News
After a spinal cord injury a number of factors impede the regeneration of nerve cells. Two of the most important of these factors are the destabilization of the cytoskeleton and the development of scar tissue.
No Comments »
Filed under: Pharmacy News
Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company’s proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, [...]
No Comments »
Filed under: Pharmacy News
British Prime Minister David Cameron said today that the United Kingdom would double its current contribution to polio eradication.
No Comments »
Filed under: Pharmacy News
LivDerma’s Dr. Joseph Gabriele has developed a unique, evidence-based transdermal delivery system to enter deep into the skin’s dermis that produces strong pharmalogical effects.
No Comments »
Filed under: Pharmacy News
A drug called etanercept can restore responsiveness to the pain-relieving effects of morphine in rats that have developed morphine tolerance, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
No Comments »
Filed under: Pharmacy News
Ben-Gurion University of the Negev and the PTT Chemical Public Company Ltd. in Thailand have signed a research and development collaboration agreement for commercial development of BGU’s proprietary green algae strain.
No Comments »
Filed under: Pharmacy News
Pain Therapeutics, today announced that it had received a $5,000,000 milestone payment from King Pharmaceuticals, its exclusive commercial partner for abuse-resistant prescription pain medications.
No Comments »
Filed under: Pharmacy News
Patients receiving nitrous oxide as part of general anesthesia for surgery may be at increased long-term risk of myocardial infarction (heart attack), reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
No Comments »
Filed under: Pharmacy News
Mylan today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nisoldipine Extended-release Tablets, 8.5 mg, 17 mg, 25.5 mg and 34 mg.
No Comments »
Filed under: Pharmacy News
